Related Experiment Video
Updated: Jul 18, 2026
11:49
Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
Published on: April 3, 2026
[Should we resect all premalignant breast lesions?]
Jean-François Delaloye1, Hans-Anton Lehr
1Département de gynécologie-obstétrique,Pr Hans-Anton Lehr, Institut universitaire de pathologie, CHUV, 1011 Lausanne.
Revue Medicale Suisse
|November 24, 2006
Summary
Premalignant breast lesions require accurate histologic examination to assess cancer risk. While some lesions indicate increased risk, most do not progress to malignancy, necessitating careful clinical management.
Area of Science:
- Pathology
- Oncology
- Breast Cancer Research
Context:
- Premalignant breast lesions are histologically defined entities.
- These lesions are associated with an elevated risk of future breast cancer development.
- However, the majority of these lesions do not progress to invasive cancer.
Purpose:
- To emphasize the critical role of histologic features in defining premalignant breast lesions.
- To highlight the variable progression potential of these lesions towards malignancy.
- To underscore the importance of accurate sampling and examination in clinical management.
Summary:
- Premalignant breast lesions are identified by specific histologic characteristics.
- These characteristics help assign an increased risk of progression to malignancy.
- Accurate sampling and thorough histologic examination are crucial for appropriate clinical management, as most lesions do not become cancerous.
Impact:
- Improved diagnostic accuracy for breast lesions.
- More precise risk stratification for patients with premalignant conditions.
- Optimized clinical decision-making, avoiding overtreatment for lesions with low malignant potential.
